2,3,7,8-Tetrachlorodibenzo-p-dioxin induces a proteomic pattern that defines cleft palate formation in mice

Abbott, 1999, AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture, Toxicol. Sci., 47, 62, 10.1093/toxsci/47.1.62 Abbott, 2005, Effects of epidermal growth factor (EGF), transforming growth factor-alpha (TGFalpha), and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fusion of embryonic palates in serum-free organ culture using wild-type, EGF knockout, and TGFalpha knockout mouse strains, Birth Defects Res. A Clin. Mol. Teratol., 73, 447, 10.1002/bdra.20133 Blackstock, 1999, Proteomics: quantitative and physical mapping of cellular proteins, Trends Biotechnol., 17, 121, 10.1016/S0167-7799(98)01245-1 Courtney, 1971, Teratology studies with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicol. Appl. Pharmacol., 20, 396, 10.1016/0041-008X(71)90282-1 Couture, 1990, A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism, Teratology, 42, 619, 10.1002/tera.1420420606 Cuervo, 2004, Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis, Development, 131, 15, 10.1242/dev.00907 Fujiwara, 2008, Morphological and immunohistochemical studies on cleft palates induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice, Congenit. Anom. (Kyoto), 48, 68, 10.1111/j.1741-4520.2008.00181.x Gan, 2009, Transforming growth factor-beta3 expression up-regulates on cleft palates induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice, Toxicol. Ind. Health, 25, 473, 10.1177/0748233709345940 Goldstone, 2006, Molecular mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin cardiovascular embryotoxicity, Drug Metab. Rev., 38, 261, 10.1080/03602530600570099 Immenschuh, 2005, Peroxiredoxins, oxidative stress, and cell proliferation, Antioxid. Redox Signal., 7, 768, 10.1089/ars.2005.7.768 Kuwabara, 2002, Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release, J. Biol. Chem., 277, 3487, 10.1074/jbc.M109360200 Leite, 2002, Chemical exposure during pregnancy and oral clefts in newborns, Cad. Saude Publica, 18, 17, 10.1590/S0102-311X2002000100003 Lim, 2007, Suppression of endogenous antioxidant enzymes by 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in chicken liver during development, Arch. Environ. Contam. Toxicol., 52, 590, 10.1007/s00244-006-0168-2 Little, 2004, Smoking and orofacial clefts: a United Kingdom-based case–control study, Cleft Palate Craniofac. J., 41, 381, 10.1597/02-142.1 Murray, 2002, Gene/environment causes of cleft lip and/or palate, Clin. Genet., 61, 248, 10.1034/j.1399-0004.2002.610402.x Pandey, 2000, Proteomics to study genes and genomes, Nature, 405, 837, 10.1038/35015709 Saussez, 2006, Galectin-7, Cell. Mol. Life Sci., 63, 686, 10.1007/s00018-005-5458-8 Service, 2000, Proteomics. Can Celera do it again?, Science, 287, 2136, 10.1126/science.287.5461.2136 Thomae, 2005, Transforming growth factor-beta3 restores fusion in palatal shelves exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin, J. Biol. Chem., 280, 12742, 10.1074/jbc.M410780200 Van Aelst, 1997, Rho GTPases and signaling networks, Genes Dev., 11, 2295, 10.1101/gad.11.18.2295 Vorderstrasse, 2004, A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation, Toxicol. Sci., 78, 248, 10.1093/toxsci/kfh062 Wehby, 2010, The impact of orofacial clefts on quality of life and healthcare use and costs, Oral Dis., 16, 3, 10.1111/j.1601-0825.2009.01588.x